In addition, treatment with the chemotherapeutic medications, etoposide and TMZ, further increased the expression levels of MRP1 in CD133-positive U251 GSLCs, presumably because of the plasticity of cancer stem cells [37,38]. The gene discussed is ABCC1; the disease is cancer.